LYTIR

Insider · SEC Form 4 · Chief Executive Officer

Jorge Santos da Silva

Filed with the SEC as Santos da Silva Jorge; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $3.0M of MLTX. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. MLTXSold: MoonLake Immunotherapeutics Jul 10, 2026 68,289 shares filed Jul 13, 2026 2,774,893 shares held directly after, as filed 10b5-1 plan filing $1.4M
  2. MLTXSold: MoonLake Immunotherapeutics Jul 9, 2026 33,936 shares filed Jul 13, 2026 2,843,182 shares held directly after, as filed 10b5-1 plan filing $679K
  3. MLTXSold: MoonLake Immunotherapeutics Jul 1, 2026 47,775 shares filed Jul 2, 2026 2,877,118 shares held directly after, as filed 10b5-1 plan filing $957K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.